• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

综述:合成查耳酮衍生物作为微管蛋白聚合抑制剂。

A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors.

机构信息

State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China.

Teaching and Research Section of Natural Medicinal Chemistry, School of Pharmacy, Guizhou Medical University, Guiyang, China.

出版信息

J Enzyme Inhib Med Chem. 2022 Dec;37(1):9-38. doi: 10.1080/14756366.2021.1976772.

DOI:10.1080/14756366.2021.1976772
PMID:34894980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8667932/
Abstract

Microtubules play an important role in the process of cell mitosis and can form a spindle in the mitotic prophase of the cell, which can pull chromosomes to the ends of the cell and then divide into two daughter cells to complete the process of mitosis. Tubulin inhibitors suppress cell proliferation by inhibiting microtubule dynamics and disrupting microtubule homeostasis. Thereby inducing a cell cycle arrest at the G2/M phase and interfering with the mitotic process. It has been found that a variety of chalcone derivatives can bind to microtubule proteins and disrupt the dynamic balance of microtubules, inhibit the proliferation of tumour cells, and exert anti-tumour effects. Consequently, a great number of studies have been conducted on chalcone derivatives targeting microtubule proteins. In this review, synthetic or natural chalcone microtubule inhibitors in recent years are described, along with their structure-activity relationship (SAR) for anticancer activity.

摘要

微管在细胞有丝分裂过程中起着重要作用,可以在细胞有丝分裂前期形成纺锤体,将染色体拉到细胞的两端,然后分裂成两个子细胞,完成有丝分裂过程。微管抑制剂通过抑制微管动力学和破坏微管内稳态来抑制细胞增殖。从而诱导细胞周期在 G2/M 期停滞,并干扰有丝分裂过程。已经发现,多种查尔酮衍生物可以与微管蛋白结合并破坏微管的动态平衡,抑制肿瘤细胞的增殖,发挥抗肿瘤作用。因此,针对微管蛋白的查尔酮衍生物进行了大量的研究。本综述描述了近年来合成或天然的查尔酮微管抑制剂及其对癌细胞活性的构效关系(SAR)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/b78f49809ef4/IENZ_A_1976772_F0021_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/6bbfc14b4555/IENZ_A_1976772_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/6b64b0980b46/IENZ_A_1976772_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/bb5de59f90fe/IENZ_A_1976772_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/24f1b92028b8/IENZ_A_1976772_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/a17f5d773ded/IENZ_A_1976772_F0005_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/173f7df48130/IENZ_A_1976772_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/649b8b42da5a/IENZ_A_1976772_F0007_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/bccb520371a0/IENZ_A_1976772_F0008_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/a0ef629990ed/IENZ_A_1976772_F0009_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/5181d3429b43/IENZ_A_1976772_F0010_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/9c0ef56d9710/IENZ_A_1976772_F0011_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/70ec2823b57e/IENZ_A_1976772_F0012_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/0bcf52cb3df8/IENZ_A_1976772_F0013_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/fb0f9a5409d1/IENZ_A_1976772_F0015_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/e9e1315ea430/IENZ_A_1976772_F0016_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/368dddaa0215/IENZ_A_1976772_F0017_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/4da114abb535/IENZ_A_1976772_F0019_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/b78f49809ef4/IENZ_A_1976772_F0021_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/6bbfc14b4555/IENZ_A_1976772_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/6b64b0980b46/IENZ_A_1976772_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/bb5de59f90fe/IENZ_A_1976772_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/24f1b92028b8/IENZ_A_1976772_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/a17f5d773ded/IENZ_A_1976772_F0005_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/173f7df48130/IENZ_A_1976772_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/649b8b42da5a/IENZ_A_1976772_F0007_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/bccb520371a0/IENZ_A_1976772_F0008_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/a0ef629990ed/IENZ_A_1976772_F0009_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/5181d3429b43/IENZ_A_1976772_F0010_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/9c0ef56d9710/IENZ_A_1976772_F0011_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/70ec2823b57e/IENZ_A_1976772_F0012_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/0bcf52cb3df8/IENZ_A_1976772_F0013_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/fb0f9a5409d1/IENZ_A_1976772_F0015_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/e9e1315ea430/IENZ_A_1976772_F0016_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/368dddaa0215/IENZ_A_1976772_F0017_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/4da114abb535/IENZ_A_1976772_F0019_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d632/8667932/b78f49809ef4/IENZ_A_1976772_F0021_C.jpg

相似文献

1
A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors.综述:合成查耳酮衍生物作为微管蛋白聚合抑制剂。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):9-38. doi: 10.1080/14756366.2021.1976772.
2
Design and synthesis of novel imidazole-chalcone derivatives as microtubule protein polymerization inhibitors to treat cervical cancer and reverse cisplatin resistance.新型咪唑查尔酮衍生物的设计与合成作为微管蛋白聚合抑制剂治疗宫颈癌并逆转顺铂耐药性。
Bioorg Chem. 2024 Jun;147:107310. doi: 10.1016/j.bioorg.2024.107310. Epub 2024 Apr 4.
3
Identification of novel non-toxic and anti-angiogenic α-fluorinated chalcones as potent colchicine binding site inhibitors.鉴定新型无毒、抗血管生成的α-氟查耳酮类化合物作为强力秋水仙碱结合位点抑制剂。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):339-354. doi: 10.1080/14756366.2021.2014831.
4
Design, synthesis, biological evaluation and molecular docking studies of new chalcone derivatives containing diaryl ether moiety as potential anticancer agents and tubulin polymerization inhibitors.新型含二芳基醚结构查尔酮衍生物的设计、合成、生物评价及作为潜在的抗癌药物和微管蛋白聚合抑制剂的分子对接研究。
Bioorg Chem. 2020 Jan;95:103565. doi: 10.1016/j.bioorg.2019.103565. Epub 2019 Dec 31.
5
Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site.以微管蛋白秋水仙碱结合位点为靶点的新型萘并查尔酮衍生物的合成、生物评价及分子模拟作为 MCF-7 乳腺癌细胞潜在的抗癌剂。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):139-144. doi: 10.1080/14756366.2019.1690479.
6
A new class of cytotoxic agents targets tubulin and disrupts microtubule dynamics.一类新型细胞毒性药物靶向微管蛋白并破坏微管动力学。
Bioorg Chem. 2021 Nov;116:105297. doi: 10.1016/j.bioorg.2021.105297. Epub 2021 Aug 30.
7
Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR.通过双重靶向微管蛋白和 TrxR,对吲哚查尔酮衍生物进行结构修饰和抗肿瘤活性评价。
Eur J Med Chem. 2022 Jan 5;227:113897. doi: 10.1016/j.ejmech.2021.113897. Epub 2021 Oct 5.
8
Synthesis of benzo[d]imidazo[2,1-b]thiazole-chalcone conjugates as microtubule targeting and apoptosis inducing agents.苯并[d]咪唑并[2,1-b]噻唑-查尔酮轭合物的合成及其作为微管靶向和诱导细胞凋亡的试剂。
Bioorg Chem. 2018 Feb;76:1-12. doi: 10.1016/j.bioorg.2017.10.019. Epub 2017 Nov 2.
9
The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in β-tubulin.该化合物米利定及其衍生物通过不可逆结合到β-微管蛋白的秋水仙素结合位点来抑制微管蛋白聚合。
J Biol Chem. 2018 Jun 15;293(24):9461-9472. doi: 10.1074/jbc.RA117.001658. Epub 2018 Apr 24.
10
Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors.新型2-氯-4-氨基嘧啶和2,6-二甲基-4-氨基嘧啶衍生物作为微管蛋白聚合抑制剂的合成与评价
Bioorg Med Chem Lett. 2018 Jun 1;28(10):1769-1775. doi: 10.1016/j.bmcl.2018.04.026. Epub 2018 Apr 12.

引用本文的文献

1
A novel thiazole-sulfonamide hybrid molecule as a promising dual tubulin/carbonic anhydrase IX inhibitor with anticancer activity.一种新型噻唑-磺酰胺杂化分子,作为一种有前景的双靶点微管蛋白/碳酸酐酶IX抑制剂,具有抗癌活性。
Front Chem. 2025 Jun 26;13:1606848. doi: 10.3389/fchem.2025.1606848. eCollection 2025.
2
Computational discovery of potential therapeutic agents against brain-eating amoeba (Naegleria fowleri).针对食脑变形虫(福氏耐格里阿米巴)的潜在治疗药物的计算发现。
PLoS One. 2025 Jul 11;20(7):e0327621. doi: 10.1371/journal.pone.0327621. eCollection 2025.
3
Design and synthesis of novel pyridopyrimidine moieties linked to coumarin ring of potentially active cytotoxic agents and their docking study.

本文引用的文献

1
A review of research progress of antitumor drugs based on tubulin targets.基于微管蛋白靶点的抗肿瘤药物研究进展综述
Transl Cancer Res. 2020 Jun;9(6):4020-4027. doi: 10.21037/tcr-20-682.
2
Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors.新型咪唑查尔酮衍生物的设计、合成及作为潜在抗癌剂和微管蛋白聚合抑制剂的生物评价。
Bioorg Chem. 2021 Jul;112:104904. doi: 10.1016/j.bioorg.2021.104904. Epub 2021 Apr 20.
3
Deciphering the key heterocyclic scaffolds in targeting microtubules, kinases and carbonic anhydrases for cancer drug development.
新型吡啶并嘧啶部分与潜在活性细胞毒性药物香豆素环相连的设计、合成及其对接研究。
Sci Rep. 2025 Jun 20;15(1):20155. doi: 10.1038/s41598-025-05325-1.
4
Amide linked chalcone derivatives, a promising class of compounds with versatile biological effects.酰胺连接的查尔酮衍生物,一类具有多种生物效应的有前景的化合物。
RSC Adv. 2025 Jun 5;15(24):19043-19068. doi: 10.1039/d5ra00834d. eCollection 2025 Jun 4.
5
SMILES-based QSAR and molecular docking studies of chalcone analogues as potential anti-colon cancer.基于SMILES的查尔酮类似物作为潜在抗结肠癌药物的定量构效关系和分子对接研究。
Sci Rep. 2025 Feb 24;15(1):6573. doi: 10.1038/s41598-025-91338-9.
6
Synthesis and crystal structure of (2)-1-[3,5-bis-(benz-yloxy)phen-yl]-3-(4-eth-oxy-phen-yl)prop-2-en-1-one.(2)-1-[3,5-双(苄氧基)苯基]-3-(4-乙氧基苯基)丙-2-烯-1-酮的合成与晶体结构
Acta Crystallogr E Crystallogr Commun. 2024 Aug 6;80(Pt 9):913-915. doi: 10.1107/S2056989024007552. eCollection 2024 Sep 1.
7
Synthesis, Anticancer Activity, and Docking Studies of Novel Hydroquinone-Chalcone-Pyrazoline Hybrid Derivatives.新型对苯二酚-查尔酮-吡唑啉杂合衍生物的合成、抗癌活性及对接研究。
Int J Mol Sci. 2024 Jul 2;25(13):7281. doi: 10.3390/ijms25137281.
8
Synthesis and Anti-gastric Cancer Activity by Targeting FGFR1 Pathway of Novel Asymmetric Bis-chalcone Compounds.新型不对称双查尔酮化合物通过靶向 FGFR1 通路的合成及抗胃癌活性。
Curr Med Chem. 2024;31(39):6521-6541. doi: 10.2174/0109298673298420240530093525.
9
Recent Advances in Pyrimidine-Based Drugs.基于嘧啶的药物的最新进展
Pharmaceuticals (Basel). 2024 Jan 11;17(1):104. doi: 10.3390/ph17010104.
10
2-Acetyl-5,8-dihydro-6-(4-methyl-3-pentenyl)-1,4-naphthohydroquinone-Derived Chalcones as Potential Anticancer Agents.2-乙酰基-5,8-二氢-6-(4-甲基-3-戊烯基)-1,4-萘二酚衍生查耳酮类化合物作为潜在的抗癌剂。
Molecules. 2023 Oct 19;28(20):7172. doi: 10.3390/molecules28207172.
解析靶向微管、激酶和碳酸酐酶的关键杂环骨架,以开发癌症药物。
Pharmacol Ther. 2021 Sep;225:107860. doi: 10.1016/j.pharmthera.2021.107860. Epub 2021 Apr 22.
4
Antimicrobial drugs bearing guanidine moieties: A review.胍基抗菌药物:综述。
Eur J Med Chem. 2021 Apr 15;216:113293. doi: 10.1016/j.ejmech.2021.113293. Epub 2021 Feb 13.
5
Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer's disease.查尔酮及其类似物:阿尔茨海默病治疗和诊断应用。
Bioorg Chem. 2021 Mar;108:104681. doi: 10.1016/j.bioorg.2021.104681. Epub 2021 Jan 29.
6
Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end?铂(IV)类抗癌药物;我们是在通往圣杯的路上,还是在走向死胡同?
J Inorg Biochem. 2021 Apr;217:111353. doi: 10.1016/j.jinorgbio.2020.111353. Epub 2021 Jan 7.
7
Synthesis, biological evaluation, and molecular docking analysis of phenstatin based indole linked chalcones as anticancer agents and tubulin polymerization inhibitors.基于苯并氮杂卓的吲哚连接查尔酮类化合物的合成、生物评价及分子对接分析作为抗癌剂和微管聚合抑制剂。
Bioorg Chem. 2020 Dec;105:104447. doi: 10.1016/j.bioorg.2020.104447. Epub 2020 Nov 1.
8
Design, synthesis and antiproliferative activity evaluation of fluorine-containing chalcone derivatives.含氟查尔酮衍生物的设计、合成及抗增殖活性评价。
J Biomol Struct Dyn. 2022 May;40(8):3525-3550. doi: 10.1080/07391102.2020.1848627. Epub 2020 Nov 17.
9
Platinum(IV) complexes conjugated with chalcone analogs as dual targeting anticancer agents: In vitro and in vivo studies.铂(IV)配合物与查耳酮类似物缀合物作为双重靶向抗癌剂:体外和体内研究。
Bioorg Chem. 2020 Dec;105:104430. doi: 10.1016/j.bioorg.2020.104430. Epub 2020 Oct 27.
10
Chalcone Derivatives and their Activities against Drug-resistant Cancers: An Overview.查尔酮衍生物及其抗耐药性癌症活性:综述。
Curr Top Med Chem. 2021;21(5):348-362. doi: 10.2174/1568026620666201022143236.